| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| Q9NWT8 (AKIP_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Small ribosomal subunit protein bS22, mitochondrial; 28S ribosomal protein S38, mitochondrial; Aurora kinase A-interacting protein; Small ribosomal subunit protein mS38; | |
| P20809 (IL11_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Interleukin-11; Adipogenesis inhibitory factor; Oprelvekin; | |
| O60232 (ZNRD2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein ZNRD2; Autoantigen p27; Protein zinc ribbon domain type 2; Sjoegren syndrome/scleroderma autoantigen 1; Zinc ribbon domain-containing protein 2; | |
| Q7LBR1 (CHM1B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Charged multivesicular body protein 1b; CHMP1.5; Chromatin-modifying protein 1b; Vacuolar protein sorting-associated protein 46-2; | |
| Q3SXP7 (SHSL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein shisa-like-1; | |
| Q9BV19 (CA050_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uncharacterized protein C1orf50; | |
| Q06830 (PRDX1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Peroxiredoxin-1; Natural killer cell-enhancing factor A; Proliferation-associated gene protein; Thioredoxin peroxidase 2; Thioredoxin-dependent peroxide reductase 2; Thioredoxin-dependent peroxiredoxin 1; | |
| Q8TEE9 (SAP25_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Histone deacetylase complex subunit SAP25; 25 kDa Sin3-associated polypeptide; Sin3 corepressor complex subunit SAP25; | |
| Q1RN00 (N3AS1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uncharacterized protein NECTIN3-AS1; | |
| Q12870 (TCF15_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transcription factor 15; Class A basic helix-loop-helix protein 40; Paraxis; Protein bHLH-EC2; | |
| P31941 (ABC3A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | DNA dC->dU-editing enzyme APOBEC-3A; Phorbolin-1; | |
| Q9H9H5 (MA6D1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | MAP6 domain-containing protein 1; 21 kDa STOP-like protein; | |
| Q9UF47 (DNJ5B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | DnaJ homolog subfamily C member 5B; Cysteine-string protein isoform beta; | |
| O60760 (HPGDS_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Hematopoietic prostaglandin D synthase; GST class-sigma; Glutathione S-transferase; Glutathione-dependent PGD synthase; Glutathione-requiring prostaglandin D synthase; Prostaglandin-H2 D-isomerase; | |
| Q8TAA1 (RNS11_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative inactive ribonuclease 11; | |
| Q9BUL9 (RPP25_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ribonuclease P protein subunit p25; | |
| Q9UBM1 (PEMT_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Phosphatidylethanolamine N-methyltransferase; PEMT2; Phospholipid methyltransferase; | |
| Q96A58 (RERG_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ras-related and estrogen-regulated growth inhibitor; | |
| Q96HU8 (DIRA2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | GTP-binding protein Di-Ras2; Distinct subgroup of the Ras family member 2; | |
| Q9H0A8 (COMD4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | COMM domain-containing protein 4; | |
| Q86X83 (COMD2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | COMM domain-containing protein 2; | |
| P78560 (CRADD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Death domain-containing protein CRADD; Caspase and RIP adapter with death domain; RIP-associated protein with a death domain; | |
| Q9NWW6 (NRK1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Nicotinamide riboside kinase 1; Nicotinic acid riboside kinase 1; Ribosylnicotinamide kinase 1; Ribosylnicotinic acid kinase 1; | |
| Q9Y6W8 (ICOS_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Inducible T-cell costimulator; Activation-inducible lymphocyte immunomediatory molecule; CD278; | |
| Q96AH8 (RAB7B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ras-related protein Rab-7b; | |
| P37802 (TAGL2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transgelin-2; Epididymis tissue protein Li 7e; SM22-alpha homolog; | |
| Q5T7R7 (CA185_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uncharacterized protein C1orf185; | |
| Q9UBS8 (RNF14_HUMAN) | Swiss-Prot | Homo sapiens (Human) | E3 ubiquitin-protein ligase RNF14; Androgen receptor-associated protein 54; HFB30; RING finger protein 14; | |
| Q8N1A6 (CD033_HUMAN) | Swiss-Prot | Homo sapiens (Human) | UPF0462 protein C4orf33; | |
| Q9UI15 (TAGL3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transgelin-3; Neuronal protein 22; Neuronal protein NP25; | |
| Q07108 (CD69_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Early activation antigen CD69; Activation inducer molecule; BL-AC/P26; C-type lectin domain family 2 member C; EA1; Early T-cell activation antigen p60; GP32/28; Leukocyte surface antigen Leu-23; MLR-3; CD69; | |
| Q86TD4 (SRCA_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sarcalumenin; | |
| P48637 (GSHB_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Glutathione synthetase; Glutathione synthase; | |
| Q9HC44 (GPBL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Vasculin-like protein 1; GC-rich promoter-binding protein 1-like 1; | |
| Q96NC0 (ZMAT2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger matrin-type protein 2; | |
| Q15928 (ZN141_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 141; | |
| O60811 (PRAM2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | PRAME family member 2; | |
| Q9ULV8 (CBLC_HUMAN) | Swiss-Prot | Homo sapiens (Human) | E3 ubiquitin-protein ligase CBL-C; RING finger protein 57; RING-type E3 ubiquitin transferase CBL-C; SH3-binding protein CBL-3; SH3-binding protein CBL-C; Signal transduction protein CBL-C; | |
| P18505 (GBRB1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Gamma-aminobutyric acid receptor subunit beta-1; GABA(A) receptor subunit beta-1; | |
| Q07002 (CDK18_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Cyclin-dependent kinase 18; Cell division protein kinase 18; PCTAIRE-motif protein kinase 3; Serine/threonine-protein kinase PCTAIRE-3; | |
| Q9BSW7 (SYT17_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Synaptotagmin-17; Protein B/K; Synaptotagmin XVII; | |
| Q5VWM4 (PRAM8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | PRAME family member 8; | |
| Q5SWL7 (PRA14_HUMAN) | Swiss-Prot | Homo sapiens (Human) | PRAME family member 14; | |
| P55084 (ECHB_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Trifunctional enzyme subunit beta, mitochondrial; TP-beta; 3-ketoacyl-CoA thiolase; 2.3.1.16; 3-oxoacyl-CoA thiolase; Acetyl-CoA acyltransferase; Beta-ketothiolase; Long chain 3-ketoacyl-CoA thiolase; LCKAT; | |
| Q5T764 (IFT1B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein IFIT1 homolog B; Interferon-induced protein with tetratricopeptide repeats 1-like protein; Interferon-induced protein with tetratricopeptide repeats 1B; | |
| Q5VXH5 (PRAM7_HUMAN) | Swiss-Prot | Homo sapiens (Human) | PRAME family member 7; | |
| Q96ER3 (SAAL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein SAAL1; Synoviocyte proliferation-associated in collagen-induced arthritis protein 1; | |
| Q8IV63 (VRK3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/threonine-protein kinase VRK3; Vaccinia-related kinase 3; | |
| X6R8R1 (ST15B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Synaptotagmin-15B; | |
| Q5VWM6 (PRA13_HUMAN) | Swiss-Prot | Homo sapiens (Human) | PRAME family member 13; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_02 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 20,652 | 17,815 | 43,031 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 15-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 30-mer | 32-mer | 33-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 48-mer | 51-mer | 56-mer | 60-mer | 62-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38,374 | 3,279 | 317 | 620 | 61 | 135 | 14 | 51 | 2 | 21 | 8 | 46 | 1 | 5 | 2 | 22 | 8 | 2 | 1 | 2 | 17 | 2 | 2 | 1 | 3 | 1 | 1 | 2 | 1 | 7 | 1 | 5 | 1 | 1 | 13 | 2 |
